CAS 209394-46-7|Ladostigil hemitartrate
| Common Name | Ladostigil hemitartrate | ||
|---|---|---|---|
| CAS Number | 209394-46-7 | Molecular Weight | 694.77 |
| Density | / | Boiling Point | 412.4ºC at 760 mmHg |
| Molecular Formula | C16H20N2O2.1/2C4H6O6 | Melting Point | / |
| MSDS | / | Flash Point | 203.2ºC |
Names
| Name | (2R,3R)-2,3-dihydroxybutanedioic acid,[(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate |
|---|---|
| Synonym | More Synonyms |
Ladostigil hemitartrate BiologicalActivity
| Description | Ladostigil (TV-3326) hemitartrate is a dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO), with an IC50 of 37.1 and 31.8 μM for MAO-B and AChE, reapectively. Ladostigil hemitartrate could increase cholinergic transmission, prevent the formation of ROS or their actions and be used for the research of depression and Alzheimer's disease[1][2]. |
|---|---|
| Related Catalog | Signaling Pathways >>Neuronal Signaling >>Monoamine OxidaseResearch Areas >>Neurological DiseaseSignaling Pathways >>Neuronal Signaling >>AChE |
| Target | MAO-B:37.1 nM (IC50) AChE:31.8 nM (IC50) |
| In Vitro | Ladostigil (1-10 µM) hemitartrate exerts neuroprotective activities, including a prevention of the fall of the mitochondrial membrane potential (ψ), attenuation of apoptotic cascades and an inhibition of ROS production induced by OS insults[2]. Ladostigil (1-10 µM) hemitartrate has a significant neuroprotective activity, including inhibition of caspase-3 activation, induction of Bcl-2 and reduction of Bad and Bax gene and protein expression in human neuroblastoma SK-N-SH cells[2]. |
| In Vivo | Ladostigil (17 mg/kg; p.o. daily for 6 weeks) hemitartrate abolishes their hyperanxiety and depressive-like behaviour in the elevated plus maze (EPM) and forced swim tests (FST) tests in adulthood from puberty to prenatally-stressed rats[4]. Ladostigil (50 μmol/kg; single p.o.) hemitartrate restores the loss of episodic memory in the object recognition test in rats[3]. Animal Model: Pathogen-free (SPF) Sprague-Dawley rats[4] Dosage: 17 mg/kg Administration: P.o. (added to the drinking water) daily for 6 weeks Result: Inhibited brain MAO-A and B by more than 60%. Reduced hyperanxiety of male and female prenatally stressed (PS) rats in the EPM and depressive-like behaviour in the FST. |
| References | [1]. Denya I, et, al. Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease. Medchemcomm. 2018 Jan 16;9(2):357-370. [2]. Weinreb O, et, al. Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment. Curr Drug Targets. 2012 Apr;13(4):483-94. [3]. Weinstock M, et, al. Ladostigil, a novel multifunctional drug for the treatment of dementia co-morbid with depression. J Neural Transm Suppl. 2006;(70):443-6. [4]. Poltyrev T, et, al. Effect of chronic treatment with ladostigil (TV-3326) on anxiogenic and depressive-like behaviour and on activity of the hypothalamic-pituitary-adrenal axis in male and female prenatally stressed rats. Psychopharmacology (Berl). 2005 Aug;181(1):118-25. |
Chemical & Physical Properties
| Boiling Point | 412.4ºC at 760 mmHg |
|---|---|
| Molecular Formula | C16H20N2O2.1/2C4H6O6 |
| Molecular Weight | 694.77 |
| Flash Point | 203.2ºC |
| Exact Mass | 694.321411 |
| PSA | 198.20000 |
| LogP | 3.35360 |
| Vapour Pressure | 5.19E-07mmHg at 25°C |
| InChIKey | PRLVBVAJMQZMJN-OGOSNNLPSA-N |
| SMILES | C#CCNC1CCc2ccc(OC(=O)N(C)CC)cc21.C#CCNC1CCc2ccc(OC(=O)N(C)CC)cc21.O=C(O)C(O)C(O)C(=O)O |
Safety Information
| Hazard Codes | Xi |
|---|
Synonyms
| ethyl-methyl-carbamic acid (R)-3-prop-2-ynylamino-indan-5-yl ester tartrate |
| TV-3326 |
| Ladostigil tartrate |
| (3R)-3-(prop-2-ynylamino)-2,3,-dihydro-1H-indan-5-yl ethyl methyl carbamate tartrate |
| [(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate |
| R(+)-6-(N-methyl-N-ethylcarbamoyloxy)-N'-propargyl-1-aminoindan tartrate |
| UNII-2J1346C51H |
| (2R,3R)-2,3-dihydroxybutanedioic acid |
| ethylmethylcarbamic acid (3R)-2,3-dihydro-3-(2-propynylamino)-1H-inden-5-yl ester (2R,3R)-2,3-dihydroxybutanedioate |
| R(+)-6-(N-methyl-N-ethylcarbamoyloxy)-N'-propargyl-1-aminoindan L-tartrate |
| TV-3219 |
| (2R,3R)-2,3-Dihydroxysuccinic acid - (3R)-3-(2-propyn-1-ylamino)-2,3-dihydro-1H-inden-5-yl ethyl(methyl)carbamate (1:2) |
